Bleeding risk with AZD6140, a reversible P2Y12 receptor antagonist, vs. clopidogrel in patients undergoing coronary artery bypass grafting in the DISPERSE2 trial

✍ Scribed by S. Husted; R. A. Harrington; C. P. Cannon; R. F. Storey; P. Mitchell; H. Emanuelsson

• Book ID: 111308975
• Publisher: John Wiley and Sons
• Year: 2009
• Tongue: English
• Weight: 148 KB
• Volume: 63
• Category: Article
• ISSN: 1368-5031
• DOI: 10.1111/j.1742-1241.2009.02030.x